Table 2.
Participant descriptive characteristic (n = 24)
| Characteristic | n (%)a |
|---|---|
| Age, years | |
| 25–35 | 4 (16.7) |
| 36–45 | 0 (0.0) |
| 46–55 | 6 (25.0) |
| 56–65 | 8 (33.3) |
| 66–75 | 6 (25.0) |
| Gender identity | |
| Cisgender male | 11 (45.8) |
| Cisgender female | 10 (41.7) |
| Non-binary | 2 (8.3) |
| Chose not to disclose | 1 (4.2) |
| Race | |
| American Indian or Alaska Native | 2 (8.3) |
| Black or African American | 7 (29.2) |
| White | 14 (58.3) |
| Chose not to disclose | 1 (4.2) |
| Ethnicity | |
| Hispanic, Latino/a/x, or of Spanish origin | 3 (12.5) |
| Education | |
| High school diploma or equivalent | 1 (4.2) |
| Some college credit, no degree | 4 (16.7) |
| Associate degreeb | 4 (16.7) |
| Bachelor’s degree | 6 (25.0) |
| Master’s degree | 5 (20.8) |
| Doctorate or professional degree | 4 (16.7) |
| U.S. geographic location of residence | |
| Midwest | 8 (33.3) |
| Northeast | 5 (20.8) |
| Southeast | 4 (16.7) |
| Southwest | 1 (4.2) |
| West | 6 (25.0) |
| Previous participation in a clinical trialc | |
| Yes | 7 (29.2) |
U.S. United States
aSome totals do not equal 100% due to rounding
bAcademic or occupational
cDrug, medical device, or vaccine